Bio Impact Capital LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $669 Million distributed in 47 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $93.2M, Crinetics Pharmaceuticals, Inc. with a value of $31.5M, Edgewise Therapeutics, Inc. with a value of $28.8M, Insmed Inc with a value of $26.9M, and Natera, Inc. with a value of $25.4M.

Examining the 13F form we can see an increase of $27.7M in the current position value, from $641M to 669M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $669 Million
Healthcare: $669 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 47
  • Current Value $669 Million
  • Prior Value $641 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.